Dr. Martens Statistics
Total Valuation
Dr. Martens has a market cap or net worth of 672.28 million. The enterprise value is 1.14 billion.
Market Cap | 672.28M |
Enterprise Value | 1.14B |
Important Dates
The next estimated earnings date is Thursday, June 5, 2025.
Earnings Date | Jun 5, 2025 |
Ex-Dividend Date | Mar 7, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -4.20% |
Shares Change (QoQ) | -2.45% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 500.03M |
Valuation Ratios
The trailing PE ratio is 17.06.
PE Ratio | 17.06 |
Forward PE | n/a |
PS Ratio | 0.62 |
PB Ratio | 1.50 |
P/TBV Ratio | 8.26 |
P/FCF Ratio | 2.32 |
P/OCF Ratio | 2.21 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.30, with an EV/FCF ratio of 3.95.
EV / Earnings | 29.04 |
EV / Sales | 1.07 |
EV / EBITDA | 6.30 |
EV / EBIT | 12.12 |
EV / FCF | 3.95 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 1.34.
Current Ratio | 2.26 |
Quick Ratio | 0.98 |
Debt / Equity | 1.34 |
Debt / EBITDA | 3.29 |
Debt / FCF | 2.08 |
Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is 8.42% and return on invested capital (ROIC) is 5.32%.
Return on Equity (ROE) | 8.42% |
Return on Assets (ROA) | 4.53% |
Return on Invested Capital (ROIC) | 5.32% |
Return on Capital Employed (ROCE) | 9.60% |
Revenue Per Employee | 410,703 |
Profits Per Employee | 14,983 |
Employee Count | 2,630 |
Asset Turnover | 0.82 |
Inventory Turnover | 0.99 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.09% in the last 52 weeks. The beta is 0.07, so Dr. Martens's price volatility has been lower than the market average.
Beta (5Y) | 0.07 |
52-Week Price Change | -56.09% |
50-Day Moving Average | 1.68 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 42.15 |
Average Volume (20 Days) | 1,084 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Dr. Martens had revenue of 1.08 billion and earned 39.40 million in profits. Earnings per share was 0.04.
Revenue | 1.08B |
Gross Profit | 707.68M |
Operating Income | 95.16M |
Pretax Income | 51.60M |
Net Income | 39.40M |
EBITDA | 113.12M |
EBIT | 95.16M |
Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 127.19 million in cash and 602.73 million in debt, giving a net cash position of -475.54 million.
Cash & Cash Equivalents | 127.19M |
Total Debt | 602.73M |
Net Cash | -475.54M |
Net Cash Per Share | n/a |
Equity (Book Value) | 448.33M |
Book Value Per Share | 0.47 |
Working Capital | 325.96M |
Cash Flow
In the last 12 months, operating cash flow was 303.85 million and capital expenditures -14.21 million, giving a free cash flow of 289.64 million.
Operating Cash Flow | 303.85M |
Capital Expenditures | -14.21M |
Free Cash Flow | 289.64M |
FCF Per Share | n/a |
Margins
Gross margin is 65.52%, with operating and profit margins of 8.81% and 3.65%.
Gross Margin | 65.52% |
Operating Margin | 8.81% |
Pretax Margin | 4.78% |
Profit Margin | 3.65% |
EBITDA Margin | 10.47% |
EBIT Margin | 8.81% |
FCF Margin | 26.81% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 3.74%.
Dividend Per Share | 0.04 |
Dividend Yield | 3.74% |
Dividend Growth (YoY) | -68.50% |
Years of Dividend Growth | n/a |
Payout Ratio | 51.02% |
Buyback Yield | 4.20% |
Shareholder Yield | 7.95% |
Earnings Yield | 5.86% |
FCF Yield | 43.08% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Dr. Martens has an Altman Z-Score of 4.86.
Altman Z-Score | 4.86 |
Piotroski F-Score | n/a |